About to go ballistic, page-2

yep , this confirms that their testing can be spread out to all forms of cancers, as opposed to breast cancer.

this essentially opens up the target market BIG TIME

just pay attention that in october/november, the US government (Medicare) will announce the rebates given for these treatments offered by IPD. now the % rebate is going to be a massive indicator of company value, as the higher the rebate, the more inclined the US population is to undergo this treatment.

BUT, the fact that it now opens up to other form of cancers is just as important as the % of medicare rebate , as it will mean a lot more of the population will have access to this treatment

market hasnt realised how huge this is yet...